Editorial Comment on ‘Limited success with Clostridium Collagenase Histolyticum following FDA approval for the treatment of Peyronie’s disease’
2018 ◽
Vol 31
(1)
◽
pp. 54-55
◽
Keyword(s):
2019 ◽
Vol 32
(2)
◽
pp. 257-258
2018 ◽
Vol 31
(1)
◽
pp. 15-19
◽
2019 ◽
Vol 32
(2)
◽
pp. 251-252
◽
Keyword(s):
Keyword(s):
Keyword(s):